Bio Green Med Solution Inc Financials
This page shows Bio Green Med Solution Inc (BGMS) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 28 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of Bio Green Med Solution Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Bio Green Med Solution Inc has an operating margin of -1128.1%, meaning the company retains $-1128 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -27916.3% the prior year.
Bio Green Med Solution Inc's revenue surged 1637.2% year-over-year to $747K, reflecting rapid business expansion. This strong growth earns a score of 89/100.
Bio Green Med Solution Inc carries a low D/E ratio of 0.20, meaning only $0.20 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 98/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 4.70, Bio Green Med Solution Inc holds $4.70 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 94/100.
Bio Green Med Solution Inc generates a -43.8% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100.
Bio Green Med Solution Inc passes 3 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, Bio Green Med Solution Inc generates $1.59 in operating cash flow (-$4.8M OCF vs -$3.0M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Bio Green Med Solution Inc earns $-135.9 in operating income for every $1 of interest expense (-$8.4M vs $62K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Bio Green Med Solution Inc generated $747K in revenue in fiscal year 2025. This represents an increase of 1637.2% from the prior year.
Bio Green Med Solution Inc's EBITDA was -$8.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 29.8% from the prior year.
Bio Green Med Solution Inc reported -$3.0M in net income in fiscal year 2025. This represents an increase of 73.3% from the prior year.
Bio Green Med Solution Inc earned $-6.45 per diluted share (EPS) in fiscal year 2025. This represents an increase of 98.7% from the prior year.
Cash & Balance Sheet
Bio Green Med Solution Inc held $3.5M in cash against $0 in long-term debt as of fiscal year 2025.
Bio Green Med Solution Inc had 5M shares outstanding in fiscal year 2025. This represents an increase of 14529.9% from the prior year.
Margins & Returns
Bio Green Med Solution Inc's operating margin was -1128.1% in fiscal year 2025, reflecting core business profitability. This is up 26788.2 percentage points from the prior year.
Bio Green Med Solution Inc's net profit margin was -401.3% in fiscal year 2025, showing the share of revenue converted to profit. This is up 25673.1 percentage points from the prior year.
Bio Green Med Solution Inc's ROE was -43.8% in fiscal year 2025, measuring profit generated per dollar of shareholder equity.
Capital Allocation
Bio Green Med Solution Inc invested $848K in research and development in fiscal year 2025. This represents a decrease of 87.3% from the prior year.
BGMS Income Statement
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | $81K | N/A | N/A | $0-100.0% | $10K+150.0% | $4K-86.2% | $29K |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | $5K-92.6% | $68K-91.7% | $822K-6.6% | $880K-7.4% | $950K-53.0% | $2.0M-27.8% | $2.8M |
| SG&A Expenses | N/A | $1.0M-19.6% | $1.2M-70.4% | $4.2M+344.5% | $948K-23.4% | $1.2M-23.9% | $1.6M+2.7% | $1.6M |
| Operating Income | N/A | -$992K+24.7% | -$1.3M+73.8% | -$5.0M-175.5% | -$1.8M+16.0% | -$2.2M+40.3% | -$3.6M+16.3% | -$4.4M |
| Interest Expense | N/A | $9K+350.0% | $2K-66.7% | $6K-80.0% | $30K+275.0% | $8K+128.6% | -$28K-1500.0% | $2K |
| Income Tax | N/A | N/A | $2K | N/A | $1.2M+668.6% | -$210K+49.0% | -$412K+69.6% | -$1.4M |
| Net Income | N/A | -$988K+25.0% | -$1.3M-1527.2% | -$81K+97.3% | -$3.1M-56.0% | -$2.0M+39.9% | -$3.3M-10.6% | -$2.9M |
| EPS (Diluted) | N/A | $-1.31-33.7% | $-0.98 | $0.00 | N/A | $-43.80 | $-172.18-7485.0% | $-2.27 |
BGMS Balance Sheet
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $8.2M+0.3% | $8.2M+85.4% | $4.4M+17.9% | $3.7M-8.8% | $4.1M-23.9% | $5.4M-34.3% | $8.2M+32.8% | $6.2M |
| Current Assets | $6.3M-2.9% | $6.4M+47.0% | $4.4M+18.0% | $3.7M+1.1% | $3.7M-25.2% | $4.9M-36.3% | $7.7M+59.4% | $4.8M |
| Cash & Equivalents | $3.5M-8.7% | $3.8M-10.2% | $4.3M+23.9% | $3.5M+10.0% | $3.1M+5.2% | $3.0M-50.3% | $6.0M+114.4% | $2.8M |
| Inventory | $1.4M+1.2% | $1.4M | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | $1.3M+73.4% | $725K | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | $1.6M0.0% | $1.6M | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $1.3M+26.5% | $1.1M+37.9% | $770K+14.6% | $672K-89.3% | $6.3M-1.3% | $6.4M-11.7% | $7.2M-14.1% | $8.4M |
| Current Liabilities | $1.3M+32.9% | $1.0M+31.8% | $760K+14.6% | $663K-89.4% | $6.3M-1.3% | $6.4M-11.6% | $7.2M-13.9% | $8.3M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $6.8M-3.6% | $7.1M+95.4% | $3.6M+18.6% | $3.1M+240.8% | -$2.2M-124.1% | -$970K-197.1% | $999K+145.3% | -$2.2M |
| Retained Earnings | -$454.4M-2.3% | -$444.3M-0.6% | -$441.8M-0.3% | -$440.5M-0.2% | -$439.5M-0.7% | -$436.4M-0.5% | -$434.5M-0.8% | -$431.2M |
BGMS Cash Flow Statement
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$33K+92.4% | -$434K+58.9% | -$1.1M+67.5% | -$3.2M-139.5% | -$1.4M+55.8% | -$3.1M+0.6% | -$3.1M-538.5% | -$483K |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | $0 | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | -$3.1M | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | N/A | N/A | $0 | N/A | N/A |
| Financing Cash Flow | -$259K-8533.3% | -$3K-100.2% | $1.9M-48.4% | $3.6M+126.0% | $1.6M+161400.0% | -$1K-100.0% | $6.3M+8060.8% | -$79K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
BGMS Financial Ratios
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | -1224.7% | N/A | N/A | N/A | -21770.0%+69330.0pp | -91100.0%-76082.8pp | -15017.2% |
| Net Margin | N/A | -1219.8% | N/A | N/A | N/A | -19570.0%+61855.0pp | -81425.0%-71266.4pp | -10158.6% |
| Return on Equity | N/A | -13.9%+22.4pp | -36.3%-33.6pp | -2.6% | N/A | N/A | -326.0% | N/A |
| Return on Assets | N/A | -12.1%+17.8pp | -29.9%-27.8pp | -2.2%+72.4pp | -74.6%-38.2pp | -36.4%+3.4pp | -39.8%+8.0pp | -47.8% |
| Current Ratio | 4.70-1.7 | 6.43+0.7 | 5.77+0.2 | 5.60+5.0 | 0.59-0.2 | 0.77-0.3 | 1.07+0.5 | 0.58 |
| Debt-to-Equity | 0.20+0.0 | 0.15-0.1 | 0.210.0 | 0.22+3.1 | -2.88+3.7 | -6.55-13.7 | 7.20+11.0 | -3.79 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | -30670.0% | N/A | N/A |
Frequently Asked Questions
What is Bio Green Med Solution Inc's annual revenue?
Bio Green Med Solution Inc (BGMS) reported $747K in total revenue for fiscal year 2025. This represents a 1637.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Bio Green Med Solution Inc's revenue growing?
Bio Green Med Solution Inc (BGMS) revenue grew by 1637.2% year-over-year, from $43K to $747K in fiscal year 2025.
Is Bio Green Med Solution Inc profitable?
No, Bio Green Med Solution Inc (BGMS) reported a net income of -$3.0M in fiscal year 2025, with a net profit margin of -401.3%.
What is Bio Green Med Solution Inc's EBITDA?
Bio Green Med Solution Inc (BGMS) had EBITDA of -$8.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Bio Green Med Solution Inc's operating margin?
Bio Green Med Solution Inc (BGMS) had an operating margin of -1128.1% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Bio Green Med Solution Inc's net profit margin?
Bio Green Med Solution Inc (BGMS) had a net profit margin of -401.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Bio Green Med Solution Inc's return on equity (ROE)?
Bio Green Med Solution Inc (BGMS) has a return on equity of -43.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Bio Green Med Solution Inc's operating cash flow?
Bio Green Med Solution Inc (BGMS) generated -$4.8M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Bio Green Med Solution Inc's total assets?
Bio Green Med Solution Inc (BGMS) had $8.2M in total assets as of fiscal year 2025, including both current and long-term assets.
How much does Bio Green Med Solution Inc spend on research and development?
Bio Green Med Solution Inc (BGMS) invested $848K in research and development during fiscal year 2025.
What is Bio Green Med Solution Inc's current ratio?
Bio Green Med Solution Inc (BGMS) had a current ratio of 4.70 as of fiscal year 2025, which is generally considered healthy.
What is Bio Green Med Solution Inc's debt-to-equity ratio?
Bio Green Med Solution Inc (BGMS) had a debt-to-equity ratio of 0.20 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Bio Green Med Solution Inc's return on assets (ROA)?
Bio Green Med Solution Inc (BGMS) had a return on assets of -36.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Bio Green Med Solution Inc's cash runway?
Based on fiscal year 2025 data, Bio Green Med Solution Inc (BGMS) had $3.5M in cash against an annual operating cash burn of $4.8M. This gives an estimated cash runway of approximately 9 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Bio Green Med Solution Inc's Piotroski F-Score?
Bio Green Med Solution Inc (BGMS) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Bio Green Med Solution Inc's earnings high quality?
Bio Green Med Solution Inc (BGMS) has an earnings quality ratio of 1.59x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Bio Green Med Solution Inc cover its interest payments?
Bio Green Med Solution Inc (BGMS) has an interest coverage ratio of -135.9x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Bio Green Med Solution Inc?
Bio Green Med Solution Inc (BGMS) scores 47 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.